Product Information
NEBIVOLOL 2.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1169 per EA under NDC 59651013730. Its NADAC has been published 243 times since Feb 9, 2022.
FDA first approved this application on Dec 17, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651013730
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NEBIVOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211053FDA Approved
12/17/2021
TE Code
AB
On Market Since
12/17/2021
Pharmacological Classes
Price Statistics
The NADAC for NEBIVOLOL 2.5 MG TABLET has been published 243 times since Feb 9, 2022, and over the history we have for it it has declined 77.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1169 per EA |
|---|---|
| All-time high | $0.5244 (Mar 16, 2022) |
| All-time low | $0.0694 (Jul 17, 2024) |
| 52-week high | $0.1288 |
| 52-week low | $0.1044 |
| Median price | $0.1217 |
| Average price | $0.1674 |
| Largest weekly change | -34.4% (Jul 17, 2024) |
| Weeks tracked | 243 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nebivolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEBIVOLOL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEBIVOLOL 2.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1169 per EA (NDC 59651013730), effective Sep 30, 2026.
How has the price of NEBIVOLOL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEBIVOLOL 2.5 MG TABLET has declined 77.4%. It has been tracked across 243 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for NEBIVOLOL 2.5 MG TABLET?
Since Feb 9, 2022, the NADAC for NEBIVOLOL 2.5 MG TABLET has ranged from a low of $0.0694 (Jul 17, 2024) to a high of $0.5244 (Mar 16, 2022), with a median of $0.1217 per EA.
Are there cheaper alternatives to NEBIVOLOL 2.5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEBIVOLOL 2.5 MG TABLET, is $0.1012 per EA — about 13% below NEBIVOLOL 2.5 MG TABLET.
Who manufactures NEBIVOLOL 2.5 MG TABLET?
NEBIVOLOL 2.5 MG TABLET (NDC 59651013730) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.